drugset / Trial / NCT00003075
Fenretinide in Treating Patients With Cervical Neoplasia
RandomizedSingle-groupTriple-blindPrevention
Summary
RATIONALE: Chemoprevention uses drugs to try and prevent development of cancer. Fenretinide may be effective in treating cervical neoplasia and preventing cervical cancer. PURPOSE: Randomized double-blinded phase III trial to compare the effectiveness of fenretinide to placebo in treating patients with cervical neoplasia.
Timeline
- Start
- 1993-03-05
- Primary completion
- 2001-05-01
- Completion
- 2001-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | fenretinide | Small molecule | — | Oral |